Tired market timers are just what stocks need to rally again

• 

  Dozens of lawmakers beat stock market in 2024: Report

  The stock portfolios of more than two dozen lawmakers once again outperformed the market as bans on congressional stock trading stalled, according to a new report from the trading trackers at ...
  
  The Hill - 15h

• What snuffed out the market rally — plus, why Cramer calls Disney 'radically undervalued'

  The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
  
  CNBC - 21h
• 

  Is the US stock market in bubble territory?

  Valuations might be frothy but don’t seem nutty
  
  Financial Times - 22h

• Nvidia’s stock rallies as AI chip trade reloads for fresh run higher

  Nvidia Corp.’s stock continued its rally Monday, embodying the red-hot momentum in the artificial-intelligence chip trade so far this year.
  
  MarketWatch - 1d

• Stocks appear ‘rate sensitive once again’ as bond yields press higher

  Rising interest rates in the bond market seems to be weighing on stocks, as investors wait for an upcoming U.S. jobs report and for Wall Street banks to kick off corporate earnings season.
  
  MarketWatch - 1d
• 

  The DNC needs a tech and media leader, not just another politician

  Democrats have an opportunity today to find our way back and build a party that is better, stronger, more resilient and ready to win in 2028 and beyond.
  
  The Hill - 3d
• 

  Nvidia’s Market Value Got a $2 Trillion Boost in the AI rally of 2024

  The AI chipmaker recorded the largest market cap increase of any publicly listed company in 2024, nearly tripling in value to $3.28 trillion by the end of the year.
  
  Inc. - 5d

• The stock market rarely scores hat tricks. This strategist fears what’s next.

  The S&P 500 has managed two consecutive 20%-plus years in a row, but that has rarely led to a third great year, says this strategist.
  
  MarketWatch - 5d
• 

  Bangladesh court again rejects bail for Hindu leader who led rallies

  A court in southeastern Bangladesh has rejected a plea for bail by a jailed Hindu leader who led large rallies in the Muslim-majority country demanding better security for minority groups
  
  ABC News - 6d

More from MarketWatch

• AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal

  Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
  
  MarketWatch - 14m

• Cannabis companies say DEA has closed mind against a less-dangerous pot ranking

  Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
  
  MarketWatch - 15m

• Jobless claims fall to a nearly one-year low as Trump set to take office

  The number of people who applied for unemployment benefits in the first week of the new year fell to an 11-month low, the latest sign layoffs remain extremely low even as businesses cut back on ...
  
  MarketWatch - 21m

• Trump’s push for SALT tax reform threatened by hardline GOP budget hawks

  The path of least resistance could be $5 trillion in new government debt.
  
  MarketWatch - 22m

• The market’s wobbling. Here are BlackRock’s shields for the biggest risks.

  Here are the hedges the $11 trillion asset manager recommends for the concerns weighing on investor minds.
  
  MarketWatch - 30m

More in Business

• We're locking in roughly 100% gains on a stock that has fallen out of favor

  The stock has been downgraded by three analysts this week.
  
  CNBC - 3m

• Quantum stocks like Rigetti plunge after Nvidia's Huang says the computers are 15 to 30 years away

  Quantum computing stocks dropped Wednesday after Nvidia CEO Jensen Huang declared that useful quantum computers are likely decades in the future.
  
  CNBC - 12m

• AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal

  Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
  
  MarketWatch - 14m

• Cannabis companies say DEA has closed mind against a less-dangerous pot ranking

  Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
  
  MarketWatch - 15m

• Jobless claims fall to a nearly one-year low as Trump set to take office

  The number of people who applied for unemployment benefits in the first week of the new year fell to an 11-month low, the latest sign layoffs remain extremely low even as businesses cut back on ...
  
  MarketWatch - 21m